Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Novel therapeutic approaches for small cell lung cancer: the future has arrived.

Literature DB >> 22495056

Novel therapeutic approaches for small cell lung cancer: the future has arrived.

Maria Catherine Pietanza, Charles M Rudin.

Abstract

Entities: CellLine Chemical Disease Gene Species

Mesh：

Substances：
Antineoplastic Agents

Year: 2012 PMID： 22495056 PMCID： PMC3392558 DOI： 10.1016/j.currproblcancer.2012.03.005

Source DB: PubMed Journal: Curr Probl Cancer ISSN： 0147-0272 Impact factor: 3.187

× No keyword cloud information.

100 in total

1. Reactivity of monoclonal antibodies with ganglioside antigens in human small cell lung cancer tissues.

Authors: T Brezicka; B Bergman; S Olling; P Fredman
Journal: Lung Cancer Date: 2000-04 Impact factor: 5.705

2. Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737.

Authors: Stephen K Tahir; Xiufen Yang; Mark G Anderson; Susan E Morgan-Lappe; Aparna V Sarthy; Jun Chen; Robert B Warner; Shi-Chung Ng; Stephen W Fesik; Steve W Elmore; Saul H Rosenberg; Christin Tse
Journal: Cancer Res Date: 2007-02-01 Impact factor: 12.701

3. Synergistic antitumor effect between vorinostat and topotecan in small cell lung cancer cells is mediated by generation of reactive oxygen species and DNA damage-induced apoptosis.

Authors: Francesca Bruzzese; Monia Rocco; Silvia Castelli; Elena Di Gennaro; Alessandro Desideri; Alfredo Budillon
Journal: Mol Cancer Ther Date: 2009-11-03 Impact factor: 6.261

4. A crucial requirement for Hedgehog signaling in small cell lung cancer.

Authors: Kwon-Sik Park; Luciano G Martelotto; Martin Peifer; Martin L Sos; Anthony N Karnezis; Moe R Mahjoub; Katie Bernard; Jamie F Conklin; Anette Szczepny; Jing Yuan; Ribo Guo; Beatrice Ospina; Jeanette Falzon; Samara Bennett; Tracey J Brown; Ana Markovic; Wendy L Devereux; Cory A Ocasio; James K Chen; Tim Stearns; Roman K Thomas; Marion Dorsch; Silvia Buonamici; D Neil Watkins; Craig D Peacock; Julien Sage
Journal: Nat Med Date: 2011-10-09 Impact factor: 53.440

5. Randomized phase II study of carboplatin and etoposide with or without obatoclax mesylate in extensive-stage small cell lung cancer.

Authors: Corey J Langer; Istvan Albert; Helen J Ross; Peter Kovacs; L Johnetta Blakely; Gabor Pajkos; Attila Somfay; Petr Zatloukal; Andrzej Kazarnowicz; Mehdi M Moezi; Marshall T Schreeder; Judy Schnyder; Ada Ao-Baslock; Ashutosh K Pathak; Mark S Berger
Journal: Lung Cancer Date: 2014-05-13 Impact factor: 5.705

6. Array comparative genomic hybridization-based characterization of genetic alterations in pulmonary neuroendocrine tumors.

Authors: Johannes Voortman; Jih-Hsiang Lee; Jonathan Keith Killian; Miia Suuriniemi; Yonghong Wang; Marco Lucchi; William I Smith; Paul Meltzer; Yisong Wang; Giuseppe Giaccone
Journal: Proc Natl Acad Sci U S A Date: 2010-07-06 Impact factor: 11.205

7. Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer.

Authors: Mary E R O'Brien; Tudor-Eliade Ciuleanu; Hristo Tsekov; Yaroslav Shparyk; Branka Cuceviá; Gabor Juhasz; Nicholas Thatcher; Graham A Ross; Graham C Dane; Theresa Crofts
Journal: J Clin Oncol Date: 2006-12-01 Impact factor: 44.544

Review 8. Hedgehog signaling: progenitor phenotype in small-cell lung cancer.

Authors: D Neil Watkins; David M Berman; Stephen B Baylin
Journal: Cell Cycle Date: 2003 May-Jun Impact factor: 4.534

Review 9. Anti-cytotoxic T-lymphocyte antigen-4 antibody: the first in an emerging class of immunomodulatory antibodies for cancer treatment.

Authors: Lawrence Fong; Eric J Small
Journal: J Clin Oncol Date: 2008-10-06 Impact factor: 44.544